$3.8 million committed by the Lupus Foundation of America to support first-of-its-kind research.
Dr. Rosalind Ramsey-Goldman and Dr. José Crispín are recognized by the Lupus Foundation of America for their achievements in lupus research.
A Lupus Foundation of America study finds almost 50% of adults with lupus are misdiagnosed at the start of their journey.
New population-based analyses measure incidence and prevalence of lupus among these fast growing U.S. populations.
Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.
Patient-reported data collected in the Registry will accelerate the development of new treatments and help to unravel the mysteries of lupus.
Latest LFA Collective Data Analysis Initiative (CDAI) study yields important results and was recently published in the premier rheumatology journal, Arthritis and Rheumatology.